文献速递生殖医学

雄激素水平与不明原因不孕女性促排卵治疗后的活产率

Androgenicity and fertility treatment in women with unexplained infertility.
PubMed 文献 · Fertil Steril · 2020-01-01

本研究为AMIGOS临床试验的二次分析,纳入900对不明原因不孕夫妇,女性随机接受促性腺激素、克罗米芬或来曲唑联合宫腔内人工授精治疗。多变量逻辑回归显示,血清总睾酮、DHEAS、游离雄激素指数及临床雄激素标志物均与活产、受孕、临床妊娠或流产无关。

要点

  • 生化或临床雄激素标志物不能预测不明原因不孕女性促排卵后的活产率。
  • 血清总睾酮分位数升高与年轻、较高BMI和腰围相关,但与妊娠结局无关。
  • 临床雄激素标志物(皮脂、痤疮、多毛)与妊娠结局无关联。

核心结论

  • 在不明原因不孕女性随机队列中,雄激素的生化与临床指标均不能预测卵巢刺激治疗后的活产率。

研究设计与样本

  • AMIGOS临床试验的二次分析,纳入900对不明原因不孕夫妇,女性年龄18-40岁、月经规律、子宫腔正常、至少一侧输卵管通畅,男方活动精子≥5百万。
  • 女性随机接受促性腺激素、克罗米芬或来曲唑联合IUI治疗,最多四个治疗周期。
  • 采用多变量逻辑回归模型,调整治疗组、母亲年龄和体重指数。

主要发现

  • 随着血清总睾酮分位数升高,女性年龄更轻、体重指数更高、腰围更大,且DHEAS和游离雄激素指数值也升高。
  • 血清雄激素与活产、受孕、临床妊娠或流产结局均无关联。
  • 临床雄激素标志物与妊娠结局无关联。

临床怎么用

  • 对于不明原因不孕女性,不应依据生化或临床雄激素指标来预测促排卵治疗后的活产概率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether biochemical or clinical markers of androgenic activity predict live birth rate with ovarian stimulation in the unexplained infertility population. DESIGN: Secondary analysis of the Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation (AMIGOS) clinical trial. SETTING: Multicenter university-based clinical practices. PATIENT(S): Nine hundred couples with unexplained infertility were included. Women were 18-40 years old with regular menses, a normal uterine cavity, at least one patent fallopian tube, and a male partner with ≥5 million motile sperm. Women were randomized to receive gonadotropin, clomiphene, or letrozole with IUI for four or fewer four treatment cycles. Women were evaluated for biochemical (total testosterone, DHEAS, and free androgen index) and clinical markers of androgenic activity (sebum, acne, and hirsutism). Multivariable logistic regression models adjusting for treatment group, maternal age, and body mass index were performed. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): The primary outcome was live birth. Secondary outcomes included conception, clinical pregnancy, and pregnancy loss. RESULT(S): When comparing 900 women in the AMIGOS trial based on quartiles of serum TT, women were of younger age, higher body mass index, and higher waist circumference with increasing TT. Increasing quartiles of TT also showed increasing DHEAS and free androgen index values. Serum androgens were not associated with outcomes of live birth, conception, clinical pregnancy, or pregnancy loss. Clinical androgen markers were not associated with pregnancy outcomes. CONCLUSION(S): In a randomized cohort of women with unexplained infertility, biochemical and clinical measures of androgens did not predict live birth rate after ovarian stimulation treatment. CLINICAL TRIAL REGISTRATION NUMBER: NCT 01044862.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Wang ET, Diamond MP, Alvero R, et al. Androgenicity and fertility treatment in women with unexplained infertility. Fertil Steril. 2020. PMID: 32192596. doi:10.1016/j.fertnstert.2019.10.034

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。